Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation
W., Gilles, N., Menez, A., Doering, C
To date, incretin-based approaches for obesity management appear as the most promising and rapidly developing (Supplementary Table 1), with innovations such as once-weekly (OW) injectable triple GIPR/GCGR/GLP-1R agonist retatrutide (LY3437943), cagrilintide (long-acting amylin analogue)/semaglutide 2.4 mg (CagriSema) combination, GCGR/GLP-1R dual agonists, high-dose oral semaglutide, and oral non-peptide GLP-1 receptor agonist orforglipron, with relevant implications in terms of patients compliance and environmental sustainability
Repeated exposure to foods that trigger an allergic reaction can cause chronic inflammation and stress on the body
Lutchmansingh et al.s findings indicate that such deficiencies are due to decreased synthesis and higher non-glycaemic utilisation in patients with microvascular complications [2]
The Journal of nutritional biochemistry